source
- Capricor Therapeutics receives second FDA rejection for Duchenne cell therapy deramiocelThe U.S. Food and Drug Administration issued a second complete response letter rejecting Capricor Therapeutics' cell therapy deramiocel for Duchenne muscular dystrophy. The agency said the data did…
- Kennedy and MAHA urged to champion MMR vaccine to curb U.S. measles surgeAfter the United States lost its measles elimination status, health secretary Robert F. Kennedy Jr. used his X account to pledge action, stating the MMR vaccine remains the most effective tool to s…